{"id":13425,"date":"2019-03-05T10:00:20","date_gmt":"2019-03-05T09:00:20","guid":{"rendered":"https:\/\/www.satt.fr\/satt-international-mars-2019\/"},"modified":"2019-03-05T10:06:23","modified_gmt":"2019-03-05T09:06:23","slug":"satt-international-mars-2019","status":"publish","type":"post","link":"https:\/\/www.satt.fr\/en\/satt-international-mars-2019\/","title":{"rendered":"L’actualit\u00e9 des SATT \u00e0 l’international #1 – Mars 2019"},"content":{"rendered":"

Retrouvez les derni\u00e8res actualit\u00e9s des SATT \u00e0 l’international, avec au programme : Signature de licences exclusives mondiales, Partenariats et collaboration industrielles et acad\u00e9miques…<\/strong><\/p>\n

 <\/p>\n

EVOLUCARE, associ\u00e9 \u00e0 ADCIS, signe au CES 2019 un accord de licence exclusive et mondiale avec la SATT Ouest Valorisation et l\u2019AP_HP.\"\"<\/strong><\/span><\/p>\n

Evolucare, PME incontournable du syst\u00e8me d\u2019information hospitalier, et ADCIS, PME sp\u00e9cialis\u00e9e dans le domaine du traitement et de l\u2019analyse d\u2019images annoncent la signature d\u2019un contrat de licence exclusive et mondiale avec la SATT (*)Ouest Valorisation et l\u2019AP-HP \u00e0 l\u2019occasion du CES (Consumer ElectronicsShow) 2019 \u00e0 Las Vegas. Participant \u00e0 la d\u00e9l\u00e9gation HealthTech conduite par la SATT, les partenaires saisissent une opportunit\u00e9 unique de rayonner collectivement \u00e0 l\u2019international pour marquer, lors d\u2019un temps fort le jeudi 10 janvier, une collaboration durable pour le d\u00e9pistage automatis\u00e9 de la r\u00e9tinopathie diab\u00e9tique et, dans un avenir proche, d\u2019autres pathologies de l\u2019\u0153il. L\u2019innovation, nomm\u00e9e OphtAI, est une intelligence artificielle fruit de trois ann\u00e9es de recherche collaborative entre chercheurs, cliniciens et industriels. Associ\u00e9e \u00e0 la plateforme Evolucare de t\u00e9l\u00e9ophtalmologie, OphtAI permettra une meilleure prise en charge de presque un demi-milliard de personnes \u00e0 risque dans le monde.<\/p>\n

www.ouest-valorisation.fr\/signature-de-ces-2019<\/a><\/p>\n

—————————————————————————————————————–<\/span><\/p>\n

IRD, IPT et SATT AxLR signent un accord \u00e0 Tunis.\"\"<\/strong><\/span><\/p>\n

La SATT AxLR et l\u2019IRD (Institut de Recherche pour le D\u00e9veloppement) se sont d\u00e9plac\u00e9es \u00e0 Tunis \u00e0 la mi-d\u00e9cembre 2018 afin de conclure un accord avec l\u2019Institut Pasteur de Tunis (IPT). Cet accord tripartite a \u00e9t\u00e9 sign\u00e9 en faveur de l\u2019investissement et de la valorisation d\u2019un projet port\u00e9 par l\u2019IRD et l\u2019IPT par la SATT AxLR. La collaboration entre l\u2019IRD et l\u2019IPT a \u00e9t\u00e9 amorc\u00e9e il y a plusieurs ann\u00e9es. Elle a conduit en mai 2018 \u00e0 un d\u00e9p\u00f4t de brevet en copropri\u00e9t\u00e9 sur un nouveau vaccin prophylactique en pr\u00e9vention de la leishmaniose, une maladie jusqu\u2019alors n\u00e9glig\u00e9e.\u00c0 la suite de l\u2019\u00e9valuation des r\u00e9sultats obtenus dans le cadre d\u2019une \u00e9tude sp\u00e9cifique, la SATT AxLR a souhait\u00e9 investir et prendre en charge la valorisation du projet. L\u2019investissement ayant \u00e9t\u00e9 accept\u00e9 par son conseil d\u2019administration. Cet engagement, d\u2019un montant de 179 k\u20ac pour un projet d\u2019une dur\u00e9e de 14 mois, permettra aux \u00e9quipes de l\u2019IRD et de l\u2019IPT d\u2019obtenir les r\u00e9sultats manquants pour renforcer le brevet et pour int\u00e9resser des industriels. Les deux instituts r\u00e9aliseront les travaux de d\u00e9veloppement dans leurs installations respectives \u00e0 Tunis et \u00e0 Montpellier. Il s\u2019agit du premier projet en partenariat de la SATT AxLR avec l\u2019IPT.<\/p>\n

www.axlr.com\/ird-ipt-axlr-tunis<\/a><\/p>\n

—————————————————————————————————————–<\/span><\/p>\n

Ouest Valorisation : Le LabCom GreenCare collabore avec la prestigieuse universit\u00e9 de Yale (USA).\"\"<\/strong><\/span><\/p>\n

GreenCare, laboratoire commun \u00e0 la soci\u00e9t\u00e9 DEMETA et \u00e0 l\u2019universit\u00e9 de Rennes 1 entame une collaboration avec le Center for Green Chemistry and Green Engeneering de Yale au \u00c9tat Unis. Le partenariat consiste en un \u00e9change de doctorants afin de combiner les technologies des 2 groupes pour produire en quantit\u00e9 industrielle des produits chimiques 100% d\u2019origine biologique. Pour rappel, labellis\u00e9 fin 2017 par l\u2019ANR (Agence Nationale de Recherche), le LabCom GreenCare est le sp\u00e9cialiste de la catalyse organom\u00e9tallique pour l\u2019oxydation \u00e0 partir de m\u00e9taux non nobles. L\u2019objectif du LabCom est de peaufiner des proc\u00e9d\u00e9s de catalyse alternatifs moins toxiques et dangereux, plus \u00e9conomes en d\u00e9chets et plus \u00e9conomiques. Ce programme est \u00e9galement soutenu par la R\u00e9gion Bretagne. La SATT Ouest Valorisation a accompagn\u00e9 l\u2019universit\u00e9 de Rennes 1 et la soci\u00e9t\u00e9 Demeta pour l\u2019ing\u00e9nierie contractuelle dans le cadre de ce laboratoire commun.<\/p>\n

www.ouest-valorisation.fr\/labcom-greencare-yale<\/a><\/p>\n

—————————————————————————————————————–<\/span><\/p>\n

Le traitement des h\u00e9mangiomes infantiles, d\u00e9couverte bordelaise accompagn\u00e9e de la SATT Aquitaine, arrive maintenant en Chine.\"\"<\/strong><\/span><\/p>\n

En novembre 2018, Pierre Fabre Dermatologie et Wuhan Conform Pharmateucial Co. Ltd ont sign\u00e9 un contrat de licence de brevet. Pierre Fabre Dermatologie a accord\u00e9 une licence exclusive pour la production et la vente de solution orale au propranolol pour le traitement des h\u00e9mangiomes infantiles en Chine. Le contrat de licence conc\u00e9d\u00e9 provient de l\u2019universit\u00e9 de Bordeaux et du CHU de Bordeaux qui ont \u00e9t\u00e9 les premiers au monde \u00e0 d\u00e9couvrir que le propranolol pouvait traiter les h\u00e9mangiomes infantiles. Par la suite, l\u2019Universit\u00e9 de Bordeaux et le CHU de Bordeaux ont accord\u00e9 \u00e0 Pierre Fabre Dermatologie une licence exclusive d\u2019exploitation mondiale et le droit de sous-licencier un traitement des h\u00e9mangiomes infantiles sur la base de leur d\u00e9couverte et de leurs brevets.<\/p>\n

Communiqu\u00e9 de presse<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Retrouvez les derni\u00e8res actualit\u00e9s des SATT \u00e0 l’international, avec au programme : Signature de licences exclusives mondiales, Partenariats et collaboration industrielles et acad\u00e9miques…   EVOLUCARE, associ\u00e9 \u00e0 ADCIS, signe au CES 2019 un accord de licence exclusive et mondiale avec la SATT Ouest Valorisation et l\u2019AP_HP. Evolucare, PME incontournable du syst\u00e8me d\u2019information hospitalier, et ADCIS, […]<\/p>\n","protected":false},"author":2,"featured_media":10204,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[562,567],"tags":[],"class_list":["post-13425","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-satt-network","category-news-en"],"acf":[],"yoast_head":"\nL'actualit\u00e9 des SATT \u00e0 l'international #1 - Mars 2019 - R\u00e9seau SATT<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.satt.fr\/en\/satt-international-mars-2019\/\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/satt-international-mars-2019\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/satt-international-mars-2019\\\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/#\\\/schema\\\/person\\\/6f20a7d0bc03146f6e34a9f08d941fec\"},\"headline\":\"L’actualit\u00e9 des SATT \u00e0 l’international #1 – Mars 2019\",\"datePublished\":\"2019-03-05T09:00:20+00:00\",\"dateModified\":\"2019-03-05T09:06:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/satt-international-mars-2019\\\/\"},\"wordCount\":777,\"image\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/satt-international-mars-2019\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.satt.fr\\\/wp-content\\\/uploads\\\/2018\\\/08\\\/International.png\",\"articleSection\":[\"SATT Network\",\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/satt-international-mars-2019\\\/\",\"url\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/satt-international-mars-2019\\\/\",\"name\":\"L'actualit\u00e9 des SATT \u00e0 l'international #1 - Mars 2019 - R\u00e9seau SATT\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/satt-international-mars-2019\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/satt-international-mars-2019\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.satt.fr\\\/wp-content\\\/uploads\\\/2018\\\/08\\\/International.png\",\"datePublished\":\"2019-03-05T09:00:20+00:00\",\"dateModified\":\"2019-03-05T09:06:23+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/#\\\/schema\\\/person\\\/6f20a7d0bc03146f6e34a9f08d941fec\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/satt-international-mars-2019\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.satt.fr\\\/en\\\/satt-international-mars-2019\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/satt-international-mars-2019\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.satt.fr\\\/wp-content\\\/uploads\\\/2018\\\/08\\\/International.png\",\"contentUrl\":\"https:\\\/\\\/www.satt.fr\\\/wp-content\\\/uploads\\\/2018\\\/08\\\/International.png\",\"width\":6399,\"height\":3569},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/satt-international-mars-2019\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"L’actualit\u00e9 des SATT \u00e0 l’international #1 – Mars 2019\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/\",\"name\":\"R\u00e9seau SATT\",\"description\":\"Les Soci\u00e9t\u00e9s d'Acc\u00e9l\u00e9ration du Transfert de Technologies\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/#\\\/schema\\\/person\\\/6f20a7d0bc03146f6e34a9f08d941fec\",\"name\":\"admin\",\"url\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/author\\\/admin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"L'actualit\u00e9 des SATT \u00e0 l'international #1 - Mars 2019 - R\u00e9seau SATT","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.satt.fr\/en\/satt-international-mars-2019\/","twitter_misc":{"Written by":"admin","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.satt.fr\/en\/satt-international-mars-2019\/#article","isPartOf":{"@id":"https:\/\/www.satt.fr\/en\/satt-international-mars-2019\/"},"author":{"name":"admin","@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/6f20a7d0bc03146f6e34a9f08d941fec"},"headline":"L’actualit\u00e9 des SATT \u00e0 l’international #1 – Mars 2019","datePublished":"2019-03-05T09:00:20+00:00","dateModified":"2019-03-05T09:06:23+00:00","mainEntityOfPage":{"@id":"https:\/\/www.satt.fr\/en\/satt-international-mars-2019\/"},"wordCount":777,"image":{"@id":"https:\/\/www.satt.fr\/en\/satt-international-mars-2019\/#primaryimage"},"thumbnailUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2018\/08\/International.png","articleSection":["SATT Network","News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.satt.fr\/en\/satt-international-mars-2019\/","url":"https:\/\/www.satt.fr\/en\/satt-international-mars-2019\/","name":"L'actualit\u00e9 des SATT \u00e0 l'international #1 - Mars 2019 - R\u00e9seau SATT","isPartOf":{"@id":"https:\/\/www.satt.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.satt.fr\/en\/satt-international-mars-2019\/#primaryimage"},"image":{"@id":"https:\/\/www.satt.fr\/en\/satt-international-mars-2019\/#primaryimage"},"thumbnailUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2018\/08\/International.png","datePublished":"2019-03-05T09:00:20+00:00","dateModified":"2019-03-05T09:06:23+00:00","author":{"@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/6f20a7d0bc03146f6e34a9f08d941fec"},"breadcrumb":{"@id":"https:\/\/www.satt.fr\/en\/satt-international-mars-2019\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.satt.fr\/en\/satt-international-mars-2019\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.satt.fr\/en\/satt-international-mars-2019\/#primaryimage","url":"https:\/\/www.satt.fr\/wp-content\/uploads\/2018\/08\/International.png","contentUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2018\/08\/International.png","width":6399,"height":3569},{"@type":"BreadcrumbList","@id":"https:\/\/www.satt.fr\/en\/satt-international-mars-2019\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.satt.fr\/en\/"},{"@type":"ListItem","position":2,"name":"L’actualit\u00e9 des SATT \u00e0 l’international #1 – Mars 2019"}]},{"@type":"WebSite","@id":"https:\/\/www.satt.fr\/en\/#website","url":"https:\/\/www.satt.fr\/en\/","name":"R\u00e9seau SATT","description":"Les Soci\u00e9t\u00e9s d'Acc\u00e9l\u00e9ration du Transfert de Technologies","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.satt.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/6f20a7d0bc03146f6e34a9f08d941fec","name":"admin","url":"https:\/\/www.satt.fr\/en\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/13425","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/comments?post=13425"}],"version-history":[{"count":5,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/13425\/revisions"}],"predecessor-version":[{"id":13440,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/13425\/revisions\/13440"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/media\/10204"}],"wp:attachment":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/media?parent=13425"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/categories?post=13425"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/tags?post=13425"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}